NCT06866548 2025-12-04Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate CancerShanghai Changzheng HospitalPhase EARLY_PHASE1 Active not recruiting7 enrolled
NCT04746924 2025-06-24A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung CancerBeiGenePhase 3 Active not recruiting662 enrolled